Last Posted: Aug 01, 2019
- Psychiatric Polygenic Risk Scores as Predictor for Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in a Clinical Child and Adolescent Sample.
Jansen Arija G et al. Behavior genetics 2019 Jul - Genotype-phenotype associations in children with copy number variants associated with high neuropsychiatric risk in the UK (IMAGINE-ID): a case-control cohort study.
Chawner Samuel J R A et al. The lancet. Psychiatry 2019 May - Association of Rare Copy Number Variants With Risk of Depression.
Kendall Kimberley Marie, et al. JAMA psychiatry 2019 4 0. - Autism Spectrum Disorders and ADHD: Overlapping Phenomenology, Diagnostic Issues, and Treatment Considerations.
Antshel Kevin M et al. Current psychiatry reports 2019 Mar 21(5) 34 - Family History of Mental and Neurological Disorders and Risk of Autism.
Xie Sherlly, et al. JAMA network open 2019 3 0. (3) e190154 - Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Atomoxetine Therapy.
Brown Jacob T et al. Clinical pharmacology and therapeutics 2019 Feb - Sibling Recurrence Risk and Cross-aggregation of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder.
Miller Meghan et al. JAMA pediatrics 2018 Dec - A vast study seeks to understand the genetic underpinnings of ADHD
The Economist, November 2018 - Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
D Demontis et al, Nat Genetics, November 26, 2018 - Do borderline personality disorder and attention-deficit/hyperactivity disorder co-aggregate in families? A population-based study of 2 million Swedes.
Kuja-Halkola Ralf et al. Molecular psychiatry 2018 Oct
No hay comentarios:
Publicar un comentario